Vanguard Global Advisers
ATRC icon

Vanguard Global Advisers’s AtriCure ATRC Stock Holding History

Vanguard Global Advisers’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$543K Sell
19,394
-41
-0.2% -$1.15K ﹤0.01% 2062
2026
Q1 		$554K Buy
+19,435
New +$663K ﹤0.01% 1990

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Global Advisers's ATRC Position: Q2 2026 in Review

Vanguard Global Advisers reduced its AtriCure (ATRC) stake by 0.21% in Q2 2026, selling an estimated $1.15K and leaving 19,394 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

Vanguard Global Advisers first reported a position in ATRC in Q1 2026 and has held it in 2 quarters since. The position peaked at $554K in Q1 2026. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Vanguard Global Advisers held 19,394 shares of AtriCure worth $543K as of Q2 2026.
  • Vanguard Global Advisers sold 41 AtriCure shares in Q2 2026, an estimated $1.15K.
  • AtriCure made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2062 holding.
  • Vanguard Global Advisers first reported a position in AtriCure in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's AtriCure position peaked at $554K in Q1 2026.
  • 250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.